The European Medicines Agency’s (EMA) human medicines committee (CHMP) recommended another batch medicines for approval at ...

Merck & Co.’s kidney cancer drug Welireg, Bayer and BridgeBio’s transthyretin amyloid cardiomyopathy (ATTR-CM) therapy, and ...

TORONTO, Dec. 13, 2024 (GLOBE NEWSWIRE) -- On December 13, 2024, the Board of Directors of AGF Management Limited declared a ...

BridgeBio Pharma (BBIO) announced the Committee for Medicinal Products for Human Use or CHMP has adopted a positive opinion ...

Bayer AG won the backing of European Union regulators for its cardiology drug as the German company fights to offset the ...

The Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of acoramidis in the EU based on ...

BridgeBio Pharma (BBIO) announced that the Committee for Medicinal Products for Human Use has adopted a positive opinion recommending marketing authorization in the European Union for acoramidis for ...

The findings could potentially enable patients to be identified and treated before symptoms of ATTR-CM emerge.

When hiring job candidates to work on cell and gene therapies, companies look for more than just technical skills. Talent ...

The office of Senate Majority Leader Chuck Schumer (D-N.Y.) said that this week he will bring the HEARTS Act, the bipartisan ...